` 688029 (Micro-Tech Nanjing Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

M
688029
vs
S
Shanghai Composite

Over the past 12 months, Micro-Tech Nanjing Co Ltd has underperformed Shanghai Composite, delivering a return of +10% compared to the Shanghai Composite's +15% growth.

Stocks Performance
688029 vs Shanghai Composite

Loading
688029
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
688029 vs Shanghai Composite

Performance Gap Between 688029 and SSEC
HIDDEN
Show

Performance By Year
688029 vs Shanghai Composite

Loading
688029
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Micro-Tech Nanjing Co Ltd vs Peers

Shanghai Composite
688029
7741
ALC
COLO B
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Micro-Tech Nanjing Co Ltd
Glance View

Market Cap
15B CNY
Industry
Health Care

In the landscape of global endoscopy equipment, Micro-Tech Nanjing Co Ltd. emerges as a crucial player, vividly representing the confluence of precision medical engineering and relentless innovation. Founded in 2000, this Chinese medical device company has carved out a notable niche, specializing primarily in minimally invasive medical devices. Micro-Tech's extensive product line, which includes disposable accessories for endoscopy and interventional pulmonology, forms the backbone of its business. At its core, the company thrives on offering solutions that reduce complication rates in medical procedures and enhance patient outcomes, an endeavor that mirrors the evolving demands of modern healthcare systems worldwide. Micro-Tech's revenue model is intricately woven through its vast network of sales and distribution channels. The company employs a strategy that emphasizes direct sales to hospitals and clinics, alongside collaborations with global distributors, to ensure its products reach a wide array of healthcare professionals. This approach not only amplifies its market presence across various continents but also ensures a steady stream of revenue. By continuously investing in research and development, Micro-Tech stays at the forefront of technological advancements in its field, thus maintaining a competitive edge and ensuring a robust pipeline of innovative products that address the dynamic needs of the healthcare sector.

Micro-Tech Nanjing Co Ltd Intrinsic Value
HIDDEN
Show
Back to Top